<DOC>
	<DOCNO>NCT00339118</DOCNO>
	<brief_summary>The purpose study achieve standardization treatment low intermediate risk rhabdomyosarcoma patient , attempt improve treatment result high high risk patient addition doxorubicin induction treatment maintenance phase .</brief_summary>
	<brief_title>EpSSG ( European Soft Tissue Sarcoma Study Group ) Protocol Non-Metastatic Rhabdomyosarcoma Children</brief_title>
	<detailed_description />
	<mesh_term>Rhabdomyosarcoma</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>child non metastatic rhabdomyosarcoma adequate heart , kidney , liver function age 21 year , 6 month metastatic disease heart , kidney , liver disease</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2006</verification_date>
</DOC>